MAHA News [12.19] Vax Schedule, CBD/Cannabis, HHS on Trans Surgeries, Red Light Therapy
Description
In this December 19 episode of MAHA News, the hosts break down major health policy shifts shaping the MAHA movement. The discussion opens with President Trump’s decision to reclassify marijuana from Schedule I to Schedule III, examining the medical, research, and financial implications for cannabis, CBD, and hemp industries. The show then turns to HHS actions targeting transgender surgeries for minors, including the removal of federal funding and scrutiny of organizations like the American Academy of Pediatrics.
The conversation expands into Lyme disease, highlighting new federal acknowledgment of long-dismissed patient experiences and revelations surrounding its origins. The episode also covers food system reform, spotlighting local farm networks, raw milk resources, and corporate moves to remove harmful additives.
The second half features an in-depth interview on red light therapy, exploring its science, applications, and potential benefits for inflammation, recovery, and chronic illness. The episode closes with reflections on health sovereignty, decentralization, and the broader cultural shift underway.

![MAHA News [12.19] Vax Schedule, CBD/Cannabis, HHS on Trans Surgeries, Red Light Therapy MAHA News [12.19] Vax Schedule, CBD/Cannabis, HHS on Trans Surgeries, Red Light Therapy](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog15577742/Podcast_Thumnails_44_bs9r7.png)





















